This study aims to explore the impacts of international alliance diversity on innovation performance and the moderating effects of the types of alliances (i.e. horizontal or vertical). Based on the research stream that views alliances as a knowledge boundary expansion mechanism, this study suggests that the international alliance diversity has a positive effect on innovation performance, and that the alliance types moderate the relationship between international alliance diversity and innovation performance. The empirical analysis of the Korean pharmaceutical biotechnology firms generally supports our arguments.